Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.45
-0.31 (-3.99%)
Mar 18, 2026, 11:46 AM EDT - Market open

Solid Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-167.14-124.7-96.02-85.98-72.19-88.29
Depreciation & Amortization
1.662.462.582.412.963.92
Stock-Based Compensation
14.2410.527.637.5413.3711.63
Other Adjustments
4.918.860.5-18.251.13-0.02
Change in Receivables
---0.11-0.11-
Changes in Accounts Payable
4.982.21-0.76-5.251.21-3.43
Changes in Accrued Expenses
5.524.77-6.975.83-2.26-1.16
Changes in Unearned Revenue
----8.08-12.6420.72
Changes in Other Operating Activities
-1.95-4.12-1.143.7-9.250.03
Operating Cash Flow
-132.38-100.01-94.18-97.98-77.76-56.6
Capital Expenditures
-0.79-0.65-1.52-3.02-1.28-0.9
Sale of Property, Plant & Equipment
-0.01-0.6--
Purchases of Investments
-227.29-204.34-117.43-182.76-141.25-0.4
Proceeds from Sale of Investments
161.1188.9128.63212.8151.447.9
Payments for Business Acquisitions
---31.52--
Other Investing Activities
0.09-----
Investing Cash Flow
-66.9-16.099.6959.16-91.096.6
Long-Term Debt Issued
---2.14--
Long-Term Debt Repaid
----0.07--
Net Long-Term Debt Issued (Repaid)
---2.08--
Issuance of Common Stock
286.56128.023.1272.75134.99132.49
Net Common Stock Issued (Repurchased)
286.56128.023.1272.75134.99132.49
Other Financing Activities
-2.33-5.58----3.79
Financing Cash Flow
196.24122.443.1274.83134.99128.7
Net Cash Flow
-3.046.34-81.3736.01-33.8778.7
Free Cash Flow
-133.17-100.67-95.7-100.99-79.05-57.5
FCF Margin
----1247.74%-580.36%-
Free Cash Flow Per Share
-1.79-2.47-4.81-11.86-11.10-16.61
Levered Free Cash Flow
-157.71-120.05-103.82-88.31-93.44-69.11
Unlevered Free Cash Flow
-160.28-125.08-112.05-110.86-93.5-69.22
Updated Nov 3, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q